Obesity Hypoventilation Syndrome Clinical Trial
Official title:
Mid-and Long-term Efficacy of Ventilation Non-invasive and Continuos Positive Airway Pressure in Obesity Hypoventilation Syndrome
Verified date | January 2017 |
Source | Sociedad Española de Neumología y Cirugía Torácica |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Primary objectives: evaluate the efficacy of noninvasive ventilation (NIV) treatment versus continuous positive airway pressure (CPAP) and life style modification treatment in Obesity Hypoventilation Syndrome (OHS), with PCO2 (first phase) and days of hospitalization (second phase) analyzed as a primary variables and percentage of dropouts for medical reasons and mortality as operative variables. As secondary variables: Measure functional and clinical improvement during sleep and wakefulness, quality of life, echocardiography and the incidence and blood pressure and evolution of cardiovascular events. Objectives secondaries:role of apneogenic sleep events on molecular inflammation, endothelial damage and the genesis of diurnal hypercapnia. Methods:prospective, randomized controlled trial. Patients with OHS will be divided initially into two groups based on their apnea-hypopnea index (AHI) score, >=30 and < 30, using conventional polysomnography. The AHI >=30 group will be randomized to CPAP, NIV or life style modification treatments. The AHI <=30 groups will be randomized to NIV or life style modification treatments. Treatment efficacy at the medium- and long-term will be analyzed by comparing groups. The role of apneic events and leptin in the genesis of daytime alveolar hypoventilation will be analyzed by comparing the daytime PCO2/AHI coefficient between responders and non-responders to CPAP treatment, and the evolution of leptin levels in the four branches of the study. The role of apneic events in metabolic and biochemical alterations and endothelial dysfunction will be analyzed by comparing basal and post-treatment levels of related substances between groups, with and without significant AHI.
Status | Completed |
Enrollment | 440 |
Est. completion date | July 2017 |
Est. primary completion date | May 2013 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 15 Years to 80 Years |
Eligibility |
Inclusion Criteria: - Age between 15 and 80 years old. - Absence of moderate or severe chronic obstructive pulmonary disease (COPD). - Absence of neuromuscular, chest wall or metabolic disease which cause daytime hypercapnia. - Absence of narcolepsy or restless legs syndrome - Exceed correctly treatment of at least 30 minutes with CPAP/NIV at wakefulness. Exclusion Criteria: - Psychophysical incapacity to answer questionnaires. - Patients who are not able to be evaluated by means of quality of life questionnaires for suffering restrictive chronic disease previously diagnosed (neoplasy, chronic pain of any origin, renal failure, severe chronic obstructive pulmonary disease and any other restrictive chronic disease). - Subjects with important chronic nasal obstruction that prevents from using CPAP/NIV. - Informed consent not obtained. |
Country | Name | City | State |
---|---|---|---|
Spain | Hospital San Pedro de Alcántara. Servicio Extremeño de Salud | Cáceres |
Lead Sponsor | Collaborator |
---|---|
Sociedad Española de Neumología y Cirugía Torácica |
Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Days of hospitalization | Days of hospitalization | at least three years | |
Primary | PaCO2 | PaCO2 | at the end of first two months | |
Secondary | Number of Dropouts for Medical reasons and mortality | Number of Dropouts for Medical reasons and mortality | at least three years | |
Secondary | quality of life | quality of life | two months and three years | |
Secondary | respiratory function | respiratory function | two months and three years | |
Secondary | polysomnographic parameters | polysomnographic parameters | two months | |
Secondary | molecular inflammation and endothelial dysfunction | molecular inflammation and endothelial dysfunction | two months and three years | |
Secondary | echocardiographic parameters | echocardiographic parameters | two months and three years | |
Secondary | Blood pressure and new cardiovascular events | Blood pressure and new cardiovascular events | three years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01903135 -
Prevalence of Obesity Hypoventilation Syndrome
|
N/A | |
Recruiting |
NCT04098094 -
Outcomes of RV Dysfunction in Acute Exacerbation of Chronic Respiratory Diseases
|
||
Withdrawn |
NCT03861468 -
Medico-economics and QoL of Obese Patients Followed by Medical Analysis Laboratories (BIOSAOS )
|
N/A | |
Completed |
NCT01368614 -
AVAPS-AE Efficacy Study
|
N/A | |
Terminated |
NCT01964339 -
Obesity Hypoventilation Syndrome Prevalence Study
|
||
Completed |
NCT04108819 -
Ketogenic Diet for Obesity Hypoventilation Syndrome
|
N/A | |
Completed |
NCT02934581 -
Prevalence Rate, and Clinical Characteristics of Obesity Hypoventilation Syndrome Via Screening Patients Admitted to Medical Intensive Care Units
|
||
Terminated |
NCT03353064 -
Telemedicine for Improving Outcome in Inner City Patient Population With Hypercapneic Respiratory Failure
|
N/A | |
Completed |
NCT03085537 -
Effectiveness Monitoring of Home Non-invasive Mechanical Ventilation by Digital Diagnosis Platform
|
||
Recruiting |
NCT02980770 -
Postoperative Complications in Patients With Obesity Hypoventilation Syndrome
|
N/A | |
Completed |
NCT01483716 -
A Trial of Rehabilitation in Obesity Hypoventilation Syndrome (OHS)
|
N/A | |
Completed |
NCT01499485 -
Treatment of Metabolic Alkalosis With Acetazolamide. Effect on the Length of Mechanical Ventilation.
|
Phase 3 | |
Completed |
NCT03506906 -
The Debated Role of Sleep Studies in Patients Under Established Home Mechanical Ventilation
|
N/A | |
Terminated |
NCT02317042 -
Juno Perth Clinical Trial
|
N/A | |
Withdrawn |
NCT01104610 -
Target Volume Mode Controlled Ventilator in Obesity Hypoventilation Syndrome
|
N/A | |
Recruiting |
NCT03854058 -
Respiratory Muscle Strength in Patients With Obesity Hypoventilation Syndrome (OHS) or With a Precursor of the Disease
|
||
Not yet recruiting |
NCT05190458 -
Evaluation of High Velocity Nasal Insufflation in Management of Respiratory Failure in Patients With Overlap Syndrome
|
N/A | |
Recruiting |
NCT04100616 -
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Obesity
|
||
Completed |
NCT02342899 -
Cost Effectiveness of Outpatient Set-up of Automated NIV in Obese Patients With Chronic Respiratory Failure
|
Phase 3 | |
Completed |
NCT01757444 -
Non Invasive Ventilation : Efficacy of a New Ventilatory Mode in Patients With OHS
|
N/A |